Latest / San Antonio News Today | 2 Min News | The Daily News Now!
FDA Approves New Cholesterol Pill | San Antonio News
FDA just approved Merck’s groundbreaking new cholesterol pill, Lipfendra — the first oral drug that targets PCSK9 in the liver to slash LDL cholesterol. It’s a game-changer for high-risk patients on statins who still need more help lowering “bad” cholesterol, offering a cheaper, pill-based alternative to pricey shots. Clinical trials showed dramatic LDL reductions — over 50% in some cases — with mostly mild side effects. Take it on an empty stomach, and this fast-tracked approval signals a major leap forward in making life-saving heart disease prevention more accessible for millions. Listen…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.